Grant: Operating Grant
McGill University
$990,236.00
Structural Studies of Parkinson's Disease
EF 2012-13
Résumé
Parkinson's disease (PD) is caused by the loss of dopamine producing neurons in region of the brain known as the substantia nigra. Recently, the study of genetic forms of PD has revealed the central role of damaged mitochondria in the death of neurons. These studies shown that the protein parkin, which is absent or mutated in many familial cases of PD, is required for the identification and recycling of damaged mitochondria. Parkin is a member of a large, diverse family of proteins called ubiquitin ligases. These proteins catalyze the attachment of a small protein, ubiquitin, to targeted proteins as a signal for the degradation of the target protein. We hypothesize that in a similar manner, parkin targets damaged mitochondria for degradation. In the absence of parkin, damaged mitochondria accumulate in neurons, which leads to neuronal dysfunction and ultimately cell death.
Using structural biology, we propose to determine the three dimensional structure of parkin in order to determine how it functions to specifically target damaged mitochondria. Studies by ourselves and others have shown that parkin is recruited to cell membranes through a process that involves protein phosphorylation. We will determine the site of phosphorylation and the mechanism of activation of parkin's ubiquitin-ligase activity. These studies will deepen our understanding of the quality control system that is responsible for maintaining health mitochondria and may lead to the development of novel therapeutic strategies for slowing the progression of PD or even preventing its occurrence in susceptible populations.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
266380
Name
Gehring Kalle B
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Biochemistry & Molecular Biology - A
Projecttitle
Structural Studies of Parkinson's Disease
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$990,236
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Autophagy; Mitochondria; Mitophagy; Neurodegeneration; Nuclear Magnetic Resonance; Organellar Quality Control; Protein; Small-Angle X-Ray Scattering; Ubiquitination; X-Ray Crystallography
Abstract
Parkinson's disease (PD) is caused by the loss of dopamine producing neurons in region of the brain known as the substantia nigra. Recently, the study of genetic forms of PD has revealed the central role of damaged mitochondria in the death of neurons. These studies shown that the protein parkin, which is absent or mutated in many familial cases of PD, is required for the identification and recycling of damaged mitochondria. Parkin is a member of a large, diverse family of proteins called ubiquitin ligases. These proteins catalyze the attachment of a small protein, ubiquitin, to targeted proteins as a signal for the degradation of the target protein. We hypothesize that in a similar manner, parkin targets damaged mitochondria for degradation. In the absence of parkin, damaged mitochondria accumulate in neurons, which leads to neuronal dysfunction and ultimately cell death.
Using structural biology, we propose to determine the three dimensional structure of parkin in order to determine how it functions to specifically target damaged mitochondria. Studies by ourselves and others have shown that parkin is recruited to cell membranes through a process that involves protein phosphorylation. We will determine the site of phosphorylation and the mechanism of activation of parkin's ubiquitin-ligase activity. These studies will deepen our understanding of the quality control system that is responsible for maintaining health mitochondria and may lead to the development of novel therapeutic strategies for slowing the progression of PD or even preventing its occurrence in susceptible populations.
Competitiondate
201209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gehring, Kalle B
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $990,236~ $0~